In Utero p,p′-DDE Exposure and Infant Neurodevelopment: A Perinatal Cohort in Mexico by Torres-Sánchez, Luisa et al.
DDT (dichlorodiphenyltrichloroethane) is an
insecticide used worldwide to combat malaria
since 1942. Its principal metabolite is
dichlorodiphenyldichloroethene (DDE),
which, given its persistence and ubiquity in the
environment, is presently found in environ-
mental and human biologic samples (i.e.,
serum, maternal milk, and adipose tissue)
(Turusov et al. 2002). In Mexico, DDT was
used until 1999 (Yañez et al. 2004); and even
recently, levels of DDE have been documented
in the serum of mothers of reproductive age
(Lopez-Carrillo et al. 2001; Torres-Arreola
et al. 2003), in adipose tissue (Galván-Portillo
et al. 2002), in maternal milk (Torres-Arreola
et al. 1999), and in cord blood (Waliszewski
et al. 2000) among those residents in zones
both endemic and not endemic to malaria. 
Levels of DDE in the fetus are similar to
those found in the mother (Dorea et al. 2001),
and experimental evidence shows accumula-
tion in both the liver and brain of the fetus
(Salama et al. 1993). DDT metabolites have
neurotoxic capacity; they directly affect nerve
cells (Klaassen et al. 1986) and have endocrine
disruption effects in the hypothalamic–
hypophysis–thyroid axis (Howsdeshell 2002;
Takser et al. 2005). Alterations in the central
nervous system have been documented con-
cerning the visual–motor and cognitive func-
tions of workers chronically exposed to DDT
(Misra et al. 1984; Van Wendel de Joode et al.
2001). Evidence from two prospective infant
cohorts shows an effect between prenatal DDE
levels and hyporeflexia at 1 month of age
(Rogan et al. 1986a) and damage to psycho-
motor and mental development at 13 months
of age (Ribas-Fito et al. 2003). 
Although it is possible that prenatal expo-
sure to DDE damages early neurodevelop-
ment, no studies have examined whether there
is a critical exposure window during fetal
development for disruption of subsequent
development. No prior studies have measured
the magnitude of the effect in the presence of
other key covariables in infant neurodevelop-
ment [such as the quality of the home environ-
ment, as measured by Home Observation for
Measurement of the Environment (HOME)]
(Rogan et al. 1986a; Ribas-Fito et al. 2003).
The aim of this study was to examine the
prenatal window of exposure to DDE and its
effect on psychomotor and mental develop-
ment during the first year of life in children
of mothers who are not occupationally
exposed to this product.
Materials and Methods
Between January 2001 and June 2005, 1,585
women of reproductive age, who were in the
process of getting married, were invited to
participate in a prospective cohort study.
None of the participants had antecedents of
chronic illness (thyroid, heart, liver, kidney,
and/or gastrointestinal), none were treated
with anticonvulsants, nor were any partici-
pants breast-feeding at the time of the recruit-
ment. All participants were residents of four
municipalities in the State of Morelos,
Mexico, where DDT was used until 1998 to
combat endemic malaria.
Women who refused to participate at the
beginning of the study, or those who enrolled
and then decided not to continue, were inter-
viewed briefly about their age, educational
level, and occupation as well as the reason for
not participating. 
Each participant, once informed of the
objectives of the study, signed a letter of
informed consent. Consent was also obtained
for children once the postnatal follow-up
began. This study had the approval of the
Ethics Committee of the National Institute of
Public Health.
Baseline information. During the state’s
obligatory prenuptial marriage counseling
before the civil wedding ceremony, 1,585 eli-
gible women were identified. Those who
agreed to participate in the study were
queried by previously trained interviewers
about sociodemographic characteristics, gyne-
cologic–obstetric antecedents, alcohol and
tobacco consumption, occupation, as well as
antecedents concerning the use of pesticides.
The response rate was 62.8%.
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BACKGROUND: Evidence suggests that p,p´-dichlorodiphenyldichloroethene (DDE) affects
neurodevelopment in infants, although a critical exposure window has not yet been identiﬁed.
OBJECTIVES: Our goal was to assess the prenatal DDE exposure window and its effect on the
psychomotor development index (PDI) and mental development index (MDI) during the ﬁrst year
of life.
METHODS: We recruited 244 children whose pregnancies and deliveries were uncomplicated, and
whose mothers were monitored throughout the pregnancy. Participating mothers were not occupa-
tionally exposed to DDT (dichlorodiphenyltrichloroethane) but were residents of a zone in Mexico
with endemic malaria. We measured serum levels of DDE before pregnancy and during each
trimester of the pregnancy. We evaluated PDI and MDI of the Bayley Scales for Infant
Development (BSID-II), at 1, 3, 6, and 12 months of age. We adjusted for quality of the home
environment and maternal intellectual coefﬁcient (IQ). We used generalized mixed-effects models
for statistical analysis.
RESULTS: Third-trimester DDE level (7.8 ± 2.8 ppb) was signiﬁcantly higher than the level at base-
line, ﬁrst, and second trimesters, but the differences never exceeded 20%. Only DDE levels during
the ﬁrst trimester of pregnancy were associated with a signiﬁcant reduction in PDI (every doubled
increase of DDE level reduced the PDI 0.5 points). DDE was not associated with MDI. 
CONCLUSIONS: A critical window of exposure to DDE in utero may be the ﬁrst trimester of the preg-
nancy, and psychomotor development is a target of this compound. Residues of DDT metabolites
may present a risk of developmental delay for years after termination of DDT use.
KEY WORDS: Bayley scale, breast-feeding, cohort, in utero exposure, infant neurodevelopment,
Mexico, organochlorines, p,p´-DDE. Environ Health Perspect 115:435–439 (2007).
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were visited every 8 weeks at their homes
and/or were contacted by telephone by our
research team. Once the existence of a preg-
nancy was confirmed by means of clinical
evaluation and/or pregnancy test, an individ-
ualized home visit was planned for each of the
the ﬁrst, second, and third trimesters of preg-
nancy. The attrition rate during this stage of
the study was 27.5%.
Follow-up during pregnancy. During home
visits at each trimester, a questionnaire was
administered that collected data concerning the
progress of the pregnancy, anthropometric
measurements (maternal weight and height),
and dietary information. Dietary information
was obtained through a previously validated
semiquantitative food frequency questionnaire
(Hernandez-Avila et al. 1998). Attrition rates
varied from 6.6% in the first trimester to
10.5% in the second trimester.
Postnatal follow-up. Fifteen days before
and after the estimated date of birth, calcu-
lated from the date of the last menstrual
period, visits or telephone calls were made
with the aim of anticipating the moment of
the birth and scheduling postnatal evaluations
at 1, 3, 6 and 12 months of age. 
The information collected during postnatal
visits varied according to the age of the child.
During the visit at 1 month of age, questions
related to aspects of birth were asked (gestational
age, weight and size at birth, maternal and/or
child complications, type of birth, and initiation
of breast-feeding) and the answers were further
compared with the information contained in the
corresponding hospital discharge records. 
During subsequent visits the information
collected focused on the child’s state of health
and feeding practices. At the time of the inter-
view, the mother was asked speciﬁcally whether
the child was nursing, whether breast-feeding
was exclusive or combined with other food,
and, if not breast-feeding, the reasons for sus-
pending breast-feeding and introducing other
foods into the diet. 
Additionally, anthropometric measure-
ments were taken (weight, length, and
cephalic circumference) and neurodevelop-
ment was evaluated for each child. Attrition
rates varied from 1.5% at 3 months to 7.8%
at 1 year after the birth. 
Evaluation of neurodevelopment. We used
the Bayley Scales of Infant Development
(BSID-II) (Bayley 1993) to evaluate the mental
and psychomotor development of children dur-
ing the ﬁrst year of life. This test is valid for chil-
dren between 1 and 42 months of age, and
consists of two indices: one that evaluates men-
tal development (MDI) and the other, psy-
chomotor development (PDI). We applied a
Spanish version, used in previous studies con-
cerning neurodevelopment and environmental
exposure to lead in Mexico (Gomaa et al. 2005).
Two trained psychologists, blinded to maternal
levels of DDE during the pregnancy, adminis-
tered the BSID-II test. The interobserver con-
cordance was 0.96 for MDI and 0.98 for PDI. 
Maternal intelligence. The maternal intel-
lectual coefﬁcient (IQ) was measured using a
Spanish version of Wechsler Adult Intelligence
Scale (Wechsler 1981). 
Evaluation of the quality of the environ-
ment and home. When the children were
6 months of age, we administered a Spanish ver-
sion of the HOME Scale (Home Observation
for Measurement of the Environment)
(Caldwell and Bradley 1984). This instrument
evaluated the quality of the home environment
as a determinant of neurodevelopment and as a
possible confounder in neurotoxic studies. The
test covered parent–child communication and
interaction, the type of toys available, speciﬁc
events and other experiences that occur in the
home, as well as the general and physical quality
of the home environment. The total score of
this test was used in the analyses.
Chemical analysis. DDT metabolites.
Blood (7 mL) was taken from each of the partic-
ipants during the baseline interview and/or at
each trimester visit. After centrifugation, the
serum obtained was stored at –70°C in glass
vials (prewashed with pesticide hexane grade)
covered with a Teﬂon cap, until it was analyzed. 
We determined the levels of DDE and p,p´-
DDT in serum by means of gas chromatogra-
phy with an electron capture detector (model
3400; Varian, Inc., Palo Alto, CA, USA), fol-
lowing the protocol recommended by the U.S.
Environmental Protection Agency (1980).
Concentrations of DDE and p,p´-DDT were
reported in wet basis as nanograms per milliliter
(parts per billion). The detection limit was 0.05
ng/mL and 0.0045 ng/mL for DDE and
p,p´-DDT, respectively. All (100%) of the
serum samples were positive for DDE, whereas
only 11–22% (depending on the trimester of
pregnancy) were positive for p,p´-DDT. 
For internal quality control, each of the
serum samples was fortiﬁed with aldrin and the
average recovery was 98.15 ± 8.8%. For every
10 study samples, one sample of bovine serum
with known quantities of β-hexachlorocyclo-
hexane (β-HCH), aldrin, hexachlorobenzene
(HCB), DDE, and 1,1-dichloro-2,2-bis(p-
chorophenyl)ethane (p,p´-DDD) was analyzed,
with recovery of 100.8, 100.01, 100.91, 103.4,
104.1%, respectively. Additionally, one ran-
domly selected sample was analyzed in duplicate
in each batch with a coefﬁcient of variation of
4.37% and 0.45% for DDE and p,p´-DDT,
respectively. The results of the external quality
control comparing our laboratory (CINVES-
TAV) and M. Wolff’s laboratory in the Division
of Environmental and Occupational Medicine
at Mount Sinai Medical School showed a coefﬁ-
cient of Bland-Altman correlation between 10
split serum samples for DDE of 0.98. 
Lead analysis. Maternal blood was col-
lected in trace metal-free tubes at each
trimester of pregnancy. Blood lead levels were
determined in duplicate analysis in ESA labo-
ratories (Environmental Science Associates
Laboratories, Inc., Chelmsford, MA, USA),
using a voltammetric anodic separation
method. Samples with mean levels < 5 µg/dL
were reanalyzed using atomic absorption spec-
trometry (model 3000; Perkin-Elmer, Inc.,
Norwalk, CT, USA). External quality control
samples were provided by Centers for Disease
Control and Prevention laboratories (Atlanta,
GA, USA) and Pennsylvania State Blood Lead
Proﬁciency Testing Program (Exton, PA, USA).
Statistical analysis. Because distributions
of residuals of the regressions of Bayley
indices on concentrations of DDE in each
trimester of the pregnancy were right-skewed
and there was evidence of heteroskedasticity,
we natural log-transformed DDE. To facili-
tate interpretation of the regression coeffi-
cients of DDE, the change of PDI or MDI
for each two-times increase of DDE was cal-
culated from the natural log coefﬁcients in the
models by transforming those coefficients to
log base 2 DDE by multiplying the original
natural log coefﬁcients by 0.69.
To evaluate the effect of exposure to
DDE in each trimester and other covariates
on psychomotor (PDI) and mental develop-
ment (MDI) of the child during the ﬁrst year
of life, we used generalized mixed effects
models, as speciﬁed in the following equation: 
Yij = Xijβ + Zijγi + εij , [1]
where ij represents the observation j in the sub-
ject i; Yij corresponds to the dependent variables
mental or psychomotor development of each
subject during the ﬁrst year of life (1, 3, 6, and
12 months respectively), and Xi are the indepen-
dent variables with ﬁxed effects: levels of DDE
at each trimester of pregnancy (on a logarithm
scales), age (years), education (years), body mass
index (BMI) at the beginning of pregnancy
(kilograms per square meter), maternal IQ, his-
tory of hypertension induced by the pregnancy
(yes/no), type of birth (vaginal/cesarean), sex of
child (female/male), weight at birth (grams),
breast-feeding (yes/no) at each evaluation (1, 3,
6, and 12 months), age at each evaluation, scale
of quality of home environment (HOME Scale)
at 6 months of age, and the education level of
father (years). We also evaluated the effect of
DDE at each stage of pregnancy with separate
models, in which the independent variable of
interest corresponded to the concentration of
DDE in maternal serum for pre-pregnancy and
the corresponding trimester being studied.
Further, Zijγ are the variables with random
effects. The model assumes that the random
effects have a normal distribution, with the
average equaling 0 and with constant variation.
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dom intercept significantly improved the
adjustment of the model, we used the test for
maximum likelihood with an α < 0.05. 
Finally, for i, in PDI models we also
included random slopes of age at evaluation
and age-squared to account for the nonlinear
change in group performance with age. In
MDI models we included only a linear ran-
dom slope of age at evaluation. We assumed
an unstructured covariance.
We explored a possible modiﬁcation of the
effect of DDE on neurodevelopment caused by
breast-feeding, incorporating a term for the
interaction between both variables into the
model. A probability value ≤ 0.05 for the inter-
action was considered statistically signiﬁcant.
The diagnosis of the model consisted of the
estimation of residuals by subtraction of the
recorded values of PDI and MDI from the
model linear prediction of those values. We
also used the Shapiro-Wilks and Shapiro-
Francia tests and an evaluation using his-
tograms and normal quantile graphs to
evaluate residual normality. Graphs of model
prediction versus standardized residuals per-
mitted evaluation of residual homoskedasticity.
All analyses were made using STATA 9.2.
(StataCorp., College Station, TX, USA)
Results:
As shown in Figure 1, a total of 1,585 eligible
women were identified, of whom 996
(62.8%) agreed to participate in the cohort.
When compared with those who did not agree
to participate (589), the cohort was signifi-
cantly younger (22.6 vs. 23.8 years), had a
lower educational level (11 vs. 12.3 years), and
a higher proportion of women were dedicated
to household activities (51.3 vs. 42.8%) (data
not shown). Among 517 pregnancies recorded
in the cohort, 382 births had taken place at
the time of this report. Between pregnant
women who remained in the study and those
who were lost to follow-up, no signiﬁcant dif-
ferences (p > 0.05) were found in age (21.9 vs.
21.7 years), education level (10.7 vs. 10.4
years), occupation (45.6 vs. 44%), and parity
> 1 (18.9 vs. 14.7%) (data not shown). The
principal reasons for dropping out of the study
were a lack of interest and change in address. 
Out of 382 births, a total of 28 noneligi-
ble children were identified: four neonatal
deaths, six children who were outcomes of
twin pregnancies, one child who was prema-
ture at 25 weeks, one who was diagnosed with
congenital hypothyroidism, and another with
severe cerebral atrophy. Additionally, 15 chil-
dren were excluded for perinatal asphyxia
diagnosis and/or a birth weight of < 2 kg and
a maternal age ≤ 15 years. Eighty children
were excluded in further analysis because they
had only one postnatal evaluation and/or they
lacked data for maternal serum levels of
DDE; the final study population comprised
244 children. 
In relation to maternal age, education, paid
occupation, and parity > 1, we found no signif-
icant differences among children included in
the analysis, exclusions, and those who were
lost to follow up (Table 1). Selected character-
istics of the study population are described in
Table 2; third-trimester DDE level (7.8 ± 2.8
ppb) was signiﬁcantly higher than in the base-
line period and ﬁrst and second trimesters, but
the differences never exceeded 20% (analyses
not shown). 
Bayley MDI and PDI scores at each age are
reported in Table 3. The scores obtained
for MDI and PDI were > 90 at 1, 6, and
12 months of age. Table 4 shows that higher
DDE levels in the ﬁrst trimester of pregnancy
are signiﬁcantly associated with reduced PDI
of the child during the ﬁrst year of life. After
adjusting for breast-feeding, birth weight, age
at evaluation, and HOME, a reduction of 0.52
points in PDI was associated with every dou-
bling of DDE level (equivalent to a reduction
of ~ 2.0 points for each 10-fold increase in
DDE levels). We found no signiﬁcant associa-
tion between neurodevelopment and maternal
DDE levels at the second or third trimester.
Likewise, PDI and MDI group performances
were significantly greater at 1 month of age
compared with the other three evaluations
Prenatal p,p´-DDE exposure and neurodevelopment
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Table 1. Selected maternal characteristics of participating/nonparticipating children.
Included in the  Lost to 
Characteristic analysis (n = 244) Exclusions (n = 80) follow-up (n = 30)
Age [years (mean ± SD)] 21.7 ± 3.9 22.3 ± 4.2 22.1 ± 4.6
Education [years (mean ± SD)] 10.6 ± 3.1 11.3 ± 3.4 9.8 ± 2.8
Paid occupation (%) 44.7 53.7 43.3
Parity > 1 (%) 18.4 17.5 20.0
Statistical tests used were t-test for age, education, and birth-weight, and chi-square for occupation and parity.
Table 2. Selected characteristics of the study population. 
Percentiles
Variable n = 244 10th 90th
Maternal 
Intellectual coefﬁcient (mean ± SD) 86.7 ± 12.3 71 102
BMI (mean ± SD)a 23.2 ± 3.7 18.7 28.6
Pregnancy-induced hypertension (%)  7.0
Percent cesarean birth  55.3
Child
Percent male 56.7
Birth weight [g (mean ± SD)] 3,241 ± 428.8 2,735 3,850
Breast-feeding (%)
Not breast-fed 7.8
≤ 12 weeks 26.2
> 12 weeks 66.0
HOME Scale (mean ± SD) 30.1 ± 4.6 25 36
p,p´-DDE maternal serum levels [ng/mL, GM (GSD)]
Prepregnancy (n = 174) 6.8 (2.8) 1.7 21.8
1st trimester (n = 213) 6.4 (2.8) 1.4 18.8
2nd trimester (n = 172) 6.8 (2.9) 1.3 23.6
3rd trimester (n = 181) 7.8 (2.8) 1.8 26.3
Abbreviations: GM, geometric mean; GSD, geometric SD.
aAt ﬁrst trimester of pregnancy.
Figure 1. Prospective cohort study in Morelos,
Mexico, 2001–2005: recruitment ﬂow chart. 
*Average time between study recruitment and time to preg-
nancy: 8 months. **Four neonatal deaths, six children out-
come of twin pregnancies, one child born at 25 weeks, one
child diagnosed with congenital hypothyroidism, one child
diagnosed with severe cerebral atrophy, and 15 children
diagnosed with with perinatal asphyxia and/or birth weight
< 2 kg and maternal age ≤ 15 years. ***Only one Bayley test










274 lost to follow-up (27.5%)
Lost to follow-up
6.6% at first trimester
10.5% at second trimester
6% at third trimester
Study population
28 noneligible**
30 lost to follow-up at
  first month postnatal
80 exclusions***
*conducted during the ﬁrst year of life, regard-
less of DDE levels.
Although children who were breast-fed
had higher PDI and MDI scores than children
who were not breast-fed, this effect was statis-
tically signiﬁcant only for MDI [1.14 points;
95% confidence interval (CI), 0.08–2.20),
independent of DDE level. Both HOME
scale and birth weight were associated with a
significant increase in PDI and MDI, inde-
pendent of exposure to DDE. A difference of
one point in the HOME scale index for mea-
surements of home environment was associ-
ated with an increase in PDI of β = 0.24 (95%
CI, 0.10–0.40) and an increase in MDI of β =
0.14 (95% CI, 0.04–0.24). Each additional
kilogram in birth weight was associated with
an increase of β = 2.60 (95% CI, 1.04–4.20)
and β = 2.14 (95% CI, 1.07–3.21) for PDI
and MDI, respectively. 
The interaction between current maternal
breast-feeding and exposure to DDE during
the ﬁrst trimester was not statistically signiﬁ-
cant (β = 0.62; interaction p = 0.20) (data not
shown). There was no signiﬁcant interaction
between the HOME Scale and DDE with
regard to PDI (β = –0.02; interaction p =
0.76) or to MDI (β = –0.03; interaction p =
0·60) (data not shown).
Finally, geometric mean lead levels during
all trimesters of pregnancy in a random sub-
sample (n = 105) were between 5.5 ± 1.8
µg/dL at ﬁrst trimester and 5.6 ± 1.9 µg/dL at
third trimester, with a maximum of 27
µg/dL. The correlation between lead levels
and DDE was –0.11 (p = 0.02), and the
respective coefﬁcients for DDE with PDI and
MDI with and without adjusting for lead
were β = –0.52 versus –0.48 for the PDI and
–0.18 versus –0.12 for the MDI, respectively.
The estimates for the remaining trimesters
did not appear to be affected by the lack of
adjustment for lead (data not shown). There
was no interaction between the lead levels and
DDE in relation to PDI (data not shown). 
Discussion
The results of this study suggest that fetal
exposure to DDE during the ﬁrst trimester of
pregnancy may negatively affect psychomotor
development of the child during the ﬁrst year
of life. Additionally, we observed a protective
effect of breast-feeding on mental develop-
ment (Anderson et al. 1999). Increased birth
weight and quality of the home environment
(HOME) were associated with increased PDI
and MDI over the ﬁrst 12 months of life. 
Other studies have reported harmful
effects of exposure to DDT during pregnancy.
Using the Bayley Scale, Ribas-Fitó et al.
(2003) reported a decrease of 4.01 points
(95% CI, –6.7 to –1.3) at 13 months of age in
PDI for each doubling of DDE measured in
umbilical serum, which is greater than the
–0.52-point (95% CI, –0.96 to –0.075)
decrease associated with each doubling of ﬁrst
trimester DDE (~ 2 points for each 10-fold
increase in DDE levels) reported in this study.
They also identified a similar negative effect
caused by DDE on MDI (3.5 points), whereas
in this study we failed to detect a signiﬁcant
DDE effect during any trimester on MDI.
Their study did not control for the HOME
Scale. The lack of adjustment for HOME
Scale in studies of lead exposure results in an
overestimation of 4–5 points of lead effect on
the IQ of the child (Mink et al. 2004). 
In our study, the associations between the
HOME Scale and the two areas of development
evaluated were statistically signiﬁcant (rp = 0.15,
p = 0.000 for PDI; 0.16, p = 0.000 for MDI)
and the correlation coefficient between the
Home Scale and DDE levels was –0.19 (p =
0.000), suggesting that the children who were
most exposed to this compound in utero were
those who also had a less stimulating develop-
mental environment. Thus the DDE coefﬁcient
associated with PDI (β = –0.60; 95% CI, –0.99
to –0.17) with no adjustment by HOME scale
was 15% greater than the coefﬁcient associated
with PDI (β = –0.52) when the HOME vari-
able was included in the ﬁnal model. However,
for the MDI the difference observed between
the crude and adjusted coefficient was much
greater (β = –0.08 vs. β = –0.06), a difference of
almost 30%. Consequently, lack of control for
the HOME Scale might explain part of the
higher estimated DDE coefﬁcients in previous
studies (e.g., Ribas-Fito et al. 2003). 
In another cohort study, no association was
found between prenatal exposure to DDE and
either motor or mental development at 1 year
of age (Gladen et al. 1988). Also, in contrast to
the previous study, where a mixture of matrices
(umbilical cord, maternal serum, placenta) were
used to estimate fetal DDE exposure (Gladen
et al. 1988; Rogan et al. 1986b), we used
maternal serum samples at each trimester of
pregnancy, a more valid estimation of such
exposure (Dorea et al. 2001). 
In our 1999 pilot study, we found no
evidence of the presence of other potential con-
founders, such as PCBs, arsenic, or organo-
phosphates pesticide exposure, in the study
area (unpublished data), but we did identify
an average value for blood lead levels of
4.6 µg/dL (Moline et al. 2000). We evaluated
its impact in a random subsample of 105
mothers of this study, and results suggest that
not including the lead levels in our analysis
may have caused a slight underestimate of the
effect of DDE on neurodevelopment during
the ﬁrst trimester of pregnancy. 
To determine whether the effect of first-
trimester DDE on the PMI varied as a func-
tion of child’s age from 1 to 12 months, we
constructed an alternative model testing inter-
actions of DDE on the PMI at each of the four
age periods. None of the interactions at 3, 6, or
12 months were signiﬁcantly different from the
DDE effect at 1 month (p > 0.52), nor were
the 3- to 12-month interactions signiﬁcantly
different among themselves (p > 0.66), nor
were the 3- to 12-month interactions consid-
ered jointly different from the effect at 1
month (p > 0.57); and the model with interac-
tions represented no signiﬁcant improvement
in ﬁt to the data than the model without inter-
actions (p > 0.90). We conclude, within the
limitations of the power of our data set, that
there were no detectable differences in DDE
effect on PMI from 1 to 12 months of age.
Other potential confounders include the
levels of hemoglobin in blood during the ﬁrst
year of life. According to recent studies, 15% of
children < 1 year of age may have levels of
hemoglobin < 95 g/L (Rivera Dommarco et al.
Torres-Sánchez et al.
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Table 4. Mixed-effects modelsa for the impact of prenatal exposure to p,p´-DDE on infant psychomotor and
mental development throughout the ﬁrst year of life. 
PDI MDI
Variable Coefﬁcient 95% CI p-Value Coefﬁcient 95%CI  p-Value
p,p´-DDE (ng/mL)b
1st trimester – 0.52c –0.96 to –0.075 0.02 –0.06c –0.36 to 0.24 0.69
2nd trimester 0.23c –0.22 to 0.69 0.32 –0.12c –0.43 to 0.20 0.47
3rd trimester 0.16c –0.30 to 0.62 0.50 0.07c –0.24 to 0.40 0.64
Age at evaluation (months)d
3 –10.80 –12.10 to –9.45 0.000 –2.59 –3.55 to –1.63 0.000
6 –1.94 –3.46 to –0.42 0.01 –1.24 –2.24 to –0.24 0.01
12 –5.72 –7.46 to –3.98 0.000  –3.30 –4.67 to –1.91 0.000
Breast-feeding (yes) 1.14 –0.34 to 2.62 0.13 1.14 0.08 to 2.20 0.03
HOME Scale 0.24 0.10 to 0.40 0.001 0.14 0.04 to 0.24 0.005
Birth weight (kg) 2.60 1.04 to 4.20 0.001 2.14 1.07 to 3.21 0.000
aGeneralized mixed models effects, with the subject as a random intercept and random slopes of age at evaluation and
age-squared for PDI models. MDI models only included subject as a random intercept and random slope of age at evalua-
tion. Models were adjusted for birth weight, age at evaluation, breast-feeding, and HOME Scale at 6 months of age.
blog2DDE. cFor each doubling of p,p´-DDE. dCompared with evaluation at 1 month of age.
Table 3. Distribution of PDI and MDI in the Bayley
Scale according to age at evaluation (mean ± SD).
Age at 
evaluation (months) PDI  MDI 
1 (n = 225) 97.6 ± 7.2 98.6 ± 4.5
3 (n = 233) 86.4 ± 4.1 94.7 ± 5.5
6 (n = 227) 94.8 ± 8.7 96.3 ± 4.2
12 (n = 191) 91.0 ± 7.4 94.1 ± 7.1Prenatal p,p´-DDE exposure and neurodevelopment
Environmental Health Perspectives • VOLUME 115 | NUMBER 3 | March 2007 439
2001), which could have a negative impact on
MDI (Kordas et al. 2004) and possibly on PDI
(Beard and Connor 2003). No information is
available to explore the relationship between the
levels of DDE and the concentration of hemo-
globin in this population. However, the expected
prevalence of childhood anemia is low in chil-
dren < 1 year of age, which makes it unlikely
that the reported results have been considerably
distorted. The same consideration can be made
concerning the low prevalence in this popula-
tion of either maternal smokers (8%) or those
consuming alcohol during pregnancy (5%). 
To compare our results with those of pre-
vious studies, we reported nonlipid corrected
DDE values. However, we must acknowledge
that correcting by lipids produced essentially
the same association between DDE levels
during first trimester of pregnancy and PDI
(βDDE lipid = –0.38; p = 0.08).
The high interlaboratory concordance
coefﬁcient of DDE serum values suggests valid
estimates. In contrast, the possibility that a dif-
ferential measurement error might have dis-
torted our results is not very likely, because the
psychologists who evaluated neurodevelop-
ment did not know the maternal levels of
DDE, nor did the laboratory technicians know
of the neurodevelopment of the children. 
We did not find significant effects of
prepregnancy DDE levels on subsequent child
development. Our ﬁndings show that the criti-
cal window of exposure to DDE may be the
ﬁrst trimester of pregnancy and that the damage
appears in motor development. The first
trimester of pregnancy is critical for the central
nervous system and neuron development (Rice
and Barone 2000). Cerebral development is a
sequential and limiting process, the magnitude
of the damage being greater the earlier it occurs
(Rice and Barone 2000). The possible mecha-
nisms of neurologic damage that involve DDT
and/or its metabolites are a direct effect on motor
ﬁbers and on the motor area of the cerebral cor-
tex and their effect as endocrine disruptors in
the hypothalamic–hypophysis–thyroid axis.
To demonstrate the effect on the cerebral
cortex, animal experiments (Eriksson et al.
1992) have shown a signiﬁcant reduction in the
density of muscarinic cholinergic receptors as a
result of DDT neonatal exposure. These recep-
tors are predominantly cholinergic and are
directly involved in the process of neuronal
excitement and inhibition (Eriksson et al.
1992). A second mechanism, and probably the
most widely accepted for explaining the chronic
effect of DDT, is disruption of the thyroid sys-
tem (Takser et al. 2005). DDT, whether
directly or through its metabolites, alters the
production of thyroidal hormone and hormone
availability at target tissues, given that DDT
blocks glucuronidation. It is also known that
thyroid hormone plays an important role in
cerebral development and serves as a signal for
neuronal differentiation and maturation
(Anderson et al. 2003). Studies have demon-
strated that thyroid hormone participates in
neuronal migration and proliferation (Lavado-
Autric et al. 2003) as well as synaptogenesis and
myelinization, all processes that begin during
the first trimester of pregnancy (Rice and
Barone 2000).
The size of the effect of exposure to DDT
on child development is similar to that reported
for lead; over the 10th–90th percentile range in
levels of DDE exposure during the first
trimester of pregnancy (1.4–18.8 ng/mL) we
observed a reduction in the psychomotor devel-
opment of ~ 4 points. Other investigators
found a difference of 4 points in mental devel-
opment for lead-exposed children < 2 years of
age (Bellinger et al. 1988), where children from
the lowest tertile of exposure to this metal were
compared with those in the highest tertile (≤ 3
vs. > 10 µg/dL). 
The growing evidence that metabolic
by-products of DDT present in the mother
during pregnancy impede infant psychomotor
development over the ﬁrst 12 months of life,
combined with the long residence times of
the metabolites in the environment and in the
human body, suggests the need for increased
vigilance of prenatal exposure, even in coun-
tries that suspended DDT use years and even
decades ago. 
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